首页 >
法规速递
-
Page: Budesonide, gastro-resistant hard capsules with prolonged release properties, 3 mg, product-specific bioequivalence guidance-2025/2/12
2025-02-13查看详情 > -
Page: Budesonide, prolonged release tablets, 9 mg product- specific bioequivalence guidance-2025/2/12
2025-02-13查看详情 > -
Page: Product-specific bioequivalence guidance-2025/2/12
2025-02-13查看详情 > -
Document: HMPC meeting report on European Union herbal monographs, guidelines and other activities - 20-22 January 2025-2025/2/12
2025-02-13查看详情 > -
Document: Agenda - European medicines agencies network strategy (EMANS) to 2028 - webinar-2025/2/12
2025-02-13查看详情 > -
Page: Nilotinib product-specific bioequivalence guidance-2025/2/12
2025-02-13查看详情 > -
Document: Overview of comments received on `Nilotinib hard capsules 50, 150 and 200 mg product-specific bioequivalence guidance’ (EMA/CHMP/518671/2023)-2025/2/12
2025-02-13查看详情 > -
Document: Nilotinib hard capsules 50, 150 and 200 mg product-specific bioequivalence guidance-2025/2/12
2025-02-13查看详情 > -
Page: Executive Steering Group on Shortages and Safety of Medicinal Products-2025/2/11
2025-02-12查看详情 > -
Page: Non-clinical Working Party-2025/2/11
2025-02-12查看详情 >
